Congress Of The European Association For Cancer Research 2018
Congress Of The European Association For Cancer Research 2018
Congress Of The European Association For Cancer Research 2018
**Stem Cell Isolation and Expansion: Novel Strategies**
Emerging approaches for isolating and expanding stem cell populations are revolutionizing regenerative medicine. This article explores innovative techniques that enhance stem cell purity, yield, and functionality, paving the way for advancements in tissue repair, disease modeling, and personalized therapies.
**iPSCs: Advancing Cardiovascular Disease Research and Therapies**
Induced pluripotent stem cells (iPSCs) hold immense promise for understanding and treating cardiovascular diseases. By reprogramming patient-specific cells into iPSCs, researchers can generate disease-specific models to study disease mechanisms and discover novel therapeutic targets.
**Stem Cells and Epigenetics: Environmental Influence on Regeneration**
Epigenetics reveals how environmental factors shape gene expression without altering DNA sequence. Stem cells, with their remarkable regenerative capacity, are highly susceptible to these epigenetic modifications. This article explores the complex interplay between stem cells and epigenetics, highlighting the profound impact of environmental cues on tissue regeneration.
International Society For The Study Of Hypertension In Pregnancy World Congress 2018
Stem cell cryopreservation and biobanking face challenges in maintaining cell viability, preventing differentiation, and ensuring genetic stability. These obstacles hinder the widespread use of stem cells in regenerative medicine and research. Understanding these challenges is crucial for optimizing cryopreservation protocols and improving biobanking practices.
Congress Of International Society For Experimental Microsurgery 2018
Stem cells hold immense promise for revolutionizing the treatment of inflammatory bowel disease (IBD). Their ability to differentiate into specialized gut cells offers a potential avenue for tissue regeneration and disease mitigation. This article delves into the latest research on stem cell therapies for IBD, exploring their mechanisms of action, clinical applications, and future directions.
World Congress On Active Ageing
European Academy Of Dermatology And Venereology Congress 2018
Stem Cell Therapy for Obesity-Related Cardiomyopathy: Regenerating the Heart in Metabolic Obesity Meta Description:Can stem cell therapy reverse obesity-related cardiomyopathy? Discover how regenerative medicine restores cardiac structure, improves function, and combats metabolic heart damage. Introduction Obesity-related cardiomyopathy is a form of heart disease caused by chronic metabolic stress, excess adiposity, Read more
International Society For Peritoneal Dialysis Congress 2018
International Society For Burn Injuries Congress 2018
Congress Of The European Association For Cranio-maxillo-facial Surgery 2018
Stem Cell Therapy for Chronic Viral Hepatitis B & C: Regenerative Strategies for Liver Restoration Meta Description:Can stem cell therapy help patients with hepatitis B or C? Explore regenerative approaches to repair liver damage, reduce fibrosis, and restore hepatic function. Introduction Chronic viral hepatitis, caused by hepatitis B virus (HBV) Read more
International Fohneu Congress On Occupational Health 2018
European Congress On Epileptology 2018
International Congress On Palliative Care 2018
International Union Against Sexually Transmitted Infections Congress 2018
World Psychiatric Association International Congress 2018
Pan American Heart Failure Congress 2018
International Congress On Drug Therapy In Hiv Infection 2018
World Congress Of The International Association Of Surgeons, Gastroenterologists And Oncologists
Закон України № 4196-VI «Про внесення змін до деяких законів України у сфері охорони здоров’я щодо посилення контролю за обігом лікарських засобів, харчових продуктів для спеціального дієтичного споживання, функціональних харчових продуктів та дієтичних добавок». Закон України № 4196-VI набуде чинності з дня, наступного за днем його опублікування, крім підпункту 6 п. 2 та п. 4 розділу І, які набудуть чинності через 6 міс Read more
Консультации кардиолога Задорина Евгения Михайловича Добрый день,буду признательна вашему ответу,данные ЭКГ частота сокращений-75,PQ-0.16,QRS-0.08,QRST-0.38 синусовый ритм,горизонтальная ЭОС.Триглицериды-2.56,холестерол-6.03,ЛПВП-0.98,ЛПНП-3.89,коэф.атерогенности 5.2,умеренно расширена восходящая аорта,умеренная гипертрофия левого желудочка.Назначен диротон 5мг и атероклефит.Мне34года.Это праильное лечение?Спасибо. Добрый день, коэффициент атерогенности 5.2 – увеличен, что свидетельствует о высоком риске прогрессирования атеросклероза. Значения ЛПНП также увеличены, что подтвержает риск Read more